Walker, S <br/><br/>
Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients.  [electronic resource] 

 -  Transplantation proceedings  Jun 1998 
 - 1149-51 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/s0041-1345(98)00187-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Azathioprine--therapeutic use<br/>Cyclosporine--administration & dosage<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Graft Rejection--epidemiology<br/>Heart Transplantation--immunology<br/>Heart-Lung Transplantation--immunology<br/>Humans<br/>Hypertension--epidemiology<br/>Immunosuppressive Agents--administration & dosage<br/>Male<br/>Methylprednisolone--therapeutic use<br/>Middle Aged<br/>Postoperative Complications--epidemiology<br/>Renal Dialysis<br/>Retrospective Studies<br/>Risk Assessment<br/>Survival Analysis<br/>Time Factors